When was Cercacor founded?

Cercacor was founded in 1998 and raised its 1st funding round 18 years after it was founded.

Where is Cercacor located?

Cercacor is headquartered in Irvine, United States. It is registered at Irvine, California.

How many employees does Cercacor have?

As of Mar 31, 2026, the latest employee count at Cercacor is 119.

Is Cercacor a funded company?

Cercacor is a funded company, having raised a total of $7.89M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Jun 03, 2016.

When was the latest funding round of Cercacor?

Cercacor's latest funding was a $***** Series A round on Nov 29, 2017, with participation from 0 investor.

Where does Cercacor rank among its competitors?

Cercacor ranks 287th amongst 1296 active competitors, of which 271 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Ultrahuman, which secured $11.3M in Nov, 2025.

Who are the top competitors of Cercacor?

Cercacor's top competitors include Ultrahuman, Oura and Masimo. Among them, Ultrahuman secured the most recent funding round in November, 2025.

Cercacor - 2026 Company Profile, Team, Funding & Competitors

Company Details

Blood hemoglobin monitoring device for athletes. The company offers Ember a non-invasive multi-parameter tracker measures and tracks up to 10 parameters including hemoglobin and pulse-rate variability.

Website: www.cercacor.com/
Social
Email ID: *****@cercacor.com
Phone Number: +1 **********
Registered Address: Irvine, California

Key Metrics

Founded Year

1998

Location

Irvine, United States

Stage

Series A

Total Funding

$7.89M in 3 rounds

Latest Funding Round

Series A, Nov 29, 2017, $*****

Ranked

287^th among 1296 active competitors

Employee Count

119 as on Mar 31, 2026

Similar Companies

Ultrahuman & 1515 more

View Cercacor's full profile

Cercacor is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Cercacor Laboratories Inc CIN: 330799856 , United States, Active	Dec 31, 1999	-	65 (As on Dec 31, 2024)	-
Cercacor International Sàrl CIN: 1174191 , Switzerland, Active	Jun 21, 2022	-	-	-

Cercacor has raised a total funding of $7.89M over 3 rounds. Its first funding round was on Jun 03, 2016.

Here is the list of recent funding rounds of Cercacor:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 29, 2017	2776754	Series A	2500429	4150311	3991936	2193075
Dec 05, 2016	7440939	Series A	1408051	5601227	4887154	2325022
Jun 03, 2016	3262395	Series A	5484297	9444216	5984604	9682633

Access funding benchmarks and valuations. Sign up today!

View details of Cercacor's funding rounds and investors

The founders of Cercacor is Arun Panch.

Here are the details of Cercacor's key team members:

Arun Panch: Former Co-Founder of Cercacor.

View details of Cercacor's Founder profiles and Board Members

Cercacor's employee count trend

Cercacor has 119 employees as of Mar 26. Here is Cercacor's employee count trend over the years:

Uncover Cercacor's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cercacor include Ultrahuman, Oura and Masimo. Here is the list of Top 10 competitors of Cercacor, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ultrahuman 2019, Bengaluru (India), Series B	Provider of wearable devices and blood analysis for health and fitness	$55.3M	Steadview, Nexus Venture Partners & 43 others	80/100
2nd	Oura 2013, Oulu (Finland), Series E	Developer of smart ring providing health metrics and personalized recommendations	$1.32B	Elysian Park, Forerunner Ventures & 69 others	78/100
3rd	Masimo 1989, Irvine (United States), Acquired	Provider of wide range of devices to monitor health parameters	-	The Vertical Group, Cota Capital & 8 others	69/100
4th	Color 2013, Burlingame (United States), Series E	Provider of end-to-end Virtual clinic offering cancer-based solutions	$491M	General Catalyst, T. Rowe Price & 46 others	66/100
5th	Variant Bio 2018, Brooklyn (United States), Series B	Developer of therapeutics for the treatment of orphan indications	$128M	Lux Capital, SoftBank Vision Fund & 4 others	64/100
6th	Sibel Health 2018, Niles (United States), Series C	Developer of wireless medical monitoring devices for clinical and remote use	$71M	Steele Foundation for Hope, Gates Foundation ... & 5 others	63/100
7th	Newtopia 2008, New York City (United States), Public	Provider of health management platform for employers and insurers	$13.1M	Bloom Burton, BDC & 6 others	63/100
8th	Viome 2016, Los Alamos (United States), Series D	Provider of a machine learning based bioinformatics solutions	$302M	Khosla Ventures, Physician Partners & 14 others	62/100
9th	Openwater 2016, San Francisco (United States), Series C	Provider of imaging technologies for medical diagnosis and treatments	$100M	Khosla Ventures, Bold Capital Partners & 9 others	61/100
10th	CoachCare 2013, New York City (United States), Series C	Provider of remote patient monitoring and virtual health support services	$60.2M	Topmark Partners, Catalyst Investors & 4 others	61/100
287th	Cercacor 1998, Irvine (United States), Series A	Blood hemoglobin monitoring device for athletes	$7.89M	-	27/100